Cancer Conversations: 3 Case Challenges of Real Patients With Myelodysplastic Syndromes

episode

Decera Clinical Education Oncology Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

The Songs of John Farnham: A Living Legend | Tony Cochrane (23.09.26) 7 min · 23 Sep 2026 · Whateley

Las 10 de Erazno, el Chokolatazo, Parodias, 1h 29m · 23 Sep 2026 · Erazno y La Chokolata El Podcast

Steve Hilton & Spencer Pratt: Fixing California, Cheaper Gas, Ballot Fraud & CA Republicans 55 min · 23 Sep 2026 · All-In with Chamath, Jason, Sacks & Friedberg

Optics of Alastair Clarkson's brunt sacking | The Eminently Sensible Phil Davis (23.09.26) 1 min · 23 Sep 2026 · Whateley

The Eminently Sensible Phil Davis | Whateley (23.09.26) 13 min · 23 Sep 2026 · Whateley

The impact of Zak Butters' homecoming | The Eminently Sensible Phil Davis (23.09.26) 1 min · 23 Sep 2026 · Whateley

Report any issue

Source

Recorded14 Mar 2022

Publisherfeeds.simplecast.com ↗

Handlerec:1498575

Show notes

In this podcast episode, Amy DeZern, MD, MHS, Daniel Pollyea, MD, MS, and Amer Zeidan, MBBS, discuss challenging cases in MDS, includingTreatment for MDS after ESA failureStrategies for patients with intermediate- or high-risk MDSLuspatercept therapy in MDSMDS case challengesLink to full program, including downloadable slidesets:https://bit.ly/3tYwcYuPresenters: Amy E. DeZern, MD, MHSAssociate ProfessorOncology and MedicineThe Johns Hopkins University School of MedicineBaltimore, MarylandDaniel Pollyea, MD, MSAssociate Professor of MedicineClinical Director of Leukemia ServicesDivision of HematologyUniversity of Colorado School of MedicineAurora, ColoradoAmer Zeidan, MBBSAssociate Professor, Internal MedicineHematologyYale UniversityNew Haven, Connecticut

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in